Aurobindo receives Tenth approval from MCC South Africa

Aurobindo Pharma Ltd has announced that it has received another marketing authorization approval from Medicines Control Council (MCC) of South Africa. The Council has approved Amoxycillin Capsules in 250mg and 500mg strengths. South African market is highly regulated and plays pivotal role in its Geographical sphere. The Company, having got this approval is now well positioned to participate in Antibiotic, CNS, CVS, & ARV segments of South African markets.

Amoxicllin is a Beta-lactam antibiotic used often in treating respiratory infections. GSK is the inventor of this antibiotic and is marketed under the brand name Amoxil in most parts of the world. The Company is successfully marketing Amoxicillin in US.

Amoxicillin today commands a market of 56mio USD in South Africa.

The stock was trading at Rs.753.55, up by Rs.7.60 or 1.02%. The stock hit an intraday high of Rs.760 and low of Rs.743.05. The total traded quantity was 22043 compared to 2 week average of 222279.

Source : Equity Bulls

Keywords